Overexpression of C1GalT1 in colon cancer cells changed the O-glycan structures of FGFR2, which enhanced FGFR2 interaction with bFGF- and bFGF-mediated malignant phenotypes [24,38]. This evidence concerns the gene FGF2 and colonic neoplasm.